Contact Us
  • This field is for validation purposes and should be left unchanged.

National Cancer Institute (NCI)

A. Therapeutics (e.g. Small Molecules, Biologics, Radiomodulators, and Cell-based Therapies)
B. In Vitro and In Vivo Diagnostics (e.g. Companion Diagnostics and Prognostic Technologies)
C. Imaging Technologies (e.g. Agents, Devices, and Image-Guided Interventions)
D. Devices for Cancer Therapy (e.g. Interventional Devices, Surgical, Radiation and Ablative
Therapies)
E. Agents for Cancer Prevention (but not ?Technologies for Cancer Prevention?)
F. Development of Low Cost Technologies for Global Health
G. Development of Companion Diagnostics
H. Vaccine Development for Cancer Prevention
I. Novel Technologies to Address ?Undruggable? Drug Targets

Contact Us
  • This field is for validation purposes and should be left unchanged.